San Diego, CA – May 1, 2019 – A study published in JAMA Network Open reports that between January 2013 and September 2018, the presence of non-prescribed fentanyl among urine drug tests also positive for cocaine or methamphetamine rose 1850% and 798% respectively. This analysis provides the public with additional insight into trending increases in reported cocaine- and methamphetamine-related overdoses. Cocaine and methamphetamine related drug overdose deaths are rising sharply. These data suggest the increase may be related to the simultaneous presence of fentanyl, either added directly to the drug supply or used concomitantly.
Our Latest News
SAN DIEGO, Calif. – March 6, 2019 – Millennium Health, in close collaboration with independent clinical experts, has analyzed its proprietary database of millions of drug test results from the last five years to answer some of the most pressing questions associated with trends in medication use and substance abuse today.
San Diego, CA. – February 27, 2018 – Millennium Health, a leading health solutions company, is pleased to announce the appointment of Andrew A. Lukowiak, Ph.D. as Chief Executive Officer (CEO) effective March 1, 2018. Dr. Lukowiak has nearly 20 years of management experience in molecular diagnostics and most recently served as the Chief Operating Officer (COO) and interim-CEO of a privately held precision medicine company, where he had been a part of the management team since 2013.
SAN DIEGO – Jan. 29, 2018 – Millennium Health, LLC, a leading health solutions company, is proud to announce that it is now a credentialed laboratory under Medi-Cal, California’s Medicaid program. Physicians can now order the Company’s clinical services for Medi-Cal’s 2.5 million fee-for-service members. Millennium Health’s offerings approved under Medi-Cal include Millennium UDTSM and Millennium OFTSM. Also included is DxWound, a DNA test under Millennium Health’s genetics brand, CogenDx.
SAN DIEGO – Jan. 23, 2018 – Millennium Health, LLC has been awarded accreditation in microbiology by the College of American Pathologists (CAP), based on results of a recent on-site inspection as part of the CAP Accreditation Program. This achievement demonstrates that the Company has attained the highest standard of excellence in laboratory practices and indicates the laboratory meets these high quality standards for the DxWound molecular microbiology test. DxWound is a product of CogenDx, the genetics brand of Millennium Health, LLC.
SAN DIEGO – Dec. 14, 2017 – Millennium Health, a leading health solutions company, is pleased to announce the appointment of Robert “Bob” H. Fish as interim Chief Executive Officer (CEO), effective January 1, 2018. Mr. Fish will replace Jennifer Strickland, who is leaving the Company for another opportunity but will continue to serve in her role on Millennium Health’s Board of Directors.
SAN DIEGO – Nov. 13, 2017 – Millennium Health, a leading health solutions company, today announced the appointment of Dave Henderson as Chief Information Officer. In his position, Henderson will be responsible for all aspects of information technology strategy and implementation for the Company. He will be reporting directly to Michael Keane, chief financial officer, Millennium Health.Read More
SAN DIEGO – Oct. 4, 2017 – In 2013, the U.S. Department of Veterans Affairs (VA) Office of Acquisition and Logistics National Acquisition Center awarded Millennium Health, a leading health solutions company, a Federal Supply Schedule (FSS) contract V797D-30178 under schedule 621II Medical Laboratory Testing and Analysis contract. Recently, VA modified Millennium’s FSS contract to add its pharmacogenetic test, Millennium PGTSM. Clinicians may now use the test to help individualize prescription medication decisions for veterans, in the areas of mental health and pain management. The Veterans Health Administration operates the nation’s largest integrated health care system with more than 1,700 health-care facilities across the country and serves nine million enrolled veterans each year.
SAN DIEGO – Sept. 25, 2017 – The Mid-Atlantic Group Network of Shared Services (MAGNET GROUP), recently awarded Millennium Health, a leading health solutions company, with a contract for its pharmacogenetic test, Millennium PGTSM, and its medication monitoring services, Millennium UDTSM and Millennium OFTSM. The 9,500 health care providers within the MAGNET GROUP network now have access to these tests to help personalize treatment decisions for patients.
SAN DIEGO – Sept. 20, 2017 – A new study examined urine drug test (UDT) results to measure the co-occurrence of non-prescribed fentanyl in populations of heroin-positive healthcare patients across the United States. The study revealed a 3,000 percent increase of non-prescribed fentanyl in heroin-positive patients between January 2013 and January 2017. Regionally, 5 of the 9 U.S. Census regions exhibited a dramatic increase in the co-occurrence of fentanyl use in the heroin-positive population, with New England exhibiting the greatest jump climbing from 3 percent to 76 percent.Read More
(RADAR® / MAPP Hotline)
Monday–Friday 5:00AM-9:00PM PT
Saturday 7:00AM-12:30PM PT
Monday-Friday 6:00AM-5:00PM PT